144 related articles for article (PubMed ID: 1710137)
1. Serum and urinary levels of beta human chorionic gonadotrophin in patients with transitional cell carcinoma.
McLoughlin J; Pepera T; Bridger J; Williams G
Br J Cancer; 1991 May; 63(5):822-4. PubMed ID: 1710137
[TBL] [Abstract][Full Text] [Related]
2. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
[TBL] [Abstract][Full Text] [Related]
3. Trophoblastic metaplasia in urothelial carcinoma of the bladder.
Burry AF; Munn SR; Arnold EP; McRae CU
Br J Urol; 1986 Apr; 58(2):143-6. PubMed ID: 2421816
[TBL] [Abstract][Full Text] [Related]
4. [Biologic behavior of human chorionic gonadotropin hormone (HCGH) in transitional cell carcinomas of the bladder].
Moreno Sierra J; Gómez Ruiz JJ; Rodríguez Molina J; Blanco Jiménez E; Silmi Moyano A; Corral Rosillo J; Ortega Heredia D; Maestro de las Casas ML; Resel Estévez L
Arch Esp Urol; 1993; 46(6):469-72. PubMed ID: 7691043
[TBL] [Abstract][Full Text] [Related]
5. Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder?
Smith DJ; Evans HJ; Newman J; Chapple CR
Br J Urol; 1994 Apr; 73(4):409-12. PubMed ID: 8199829
[TBL] [Abstract][Full Text] [Related]
6. Gynecomastia and ectopic human chorionic gonadotropin production by transitional cell carcinoma of the bladder.
Nishiyama T; Washiyama K; Tanikawa T; Mineyama H; Sasagawa T; Susuki H; Kitamura Y; Sato S
Urol Int; 1992; 48(4):463-5. PubMed ID: 1413316
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies.
Dexeus F; Logothetis C; Hossan E; Samuels ML
J Urol; 1986 Aug; 136(2):403-7. PubMed ID: 2426474
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of beta human chorionic gonadotrophin in blood serum of patients with urinary bladder tumours.
Dobrowolski ZF; Byrska B; Dolezal M
Int Urol Nephrol; 1994; 26(3):301-6. PubMed ID: 7525501
[TBL] [Abstract][Full Text] [Related]
9. Ectopic production of human chorionic gonadotropin in transitional cell carcinoma of the bladder. An immunohistochemical study.
Ersev A; Ersev D; Simşek F; Taga Y; Küllü S; Akdaş A
Eur Urol; 1990; 18(3):227-30. PubMed ID: 1702059
[TBL] [Abstract][Full Text] [Related]
10. Detection of messenger RNA for the beta-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reaction.
Hotakainen K; Lintula S; Stenman J; Rintala E; Lindell O; Stenman UH
Int J Cancer; 1999 Jun; 84(3):304-8. PubMed ID: 10371351
[TBL] [Abstract][Full Text] [Related]
11. Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy?
Moutzouris G; Yannopoulos D; Barbatis C; Zaharof A; Theodorou C
Br J Urol; 1993 Dec; 72(6):907-9. PubMed ID: 7508330
[TBL] [Abstract][Full Text] [Related]
12. Composition of intact hormone and free subunits in the human chorionic gonadotrophin-like material found in serum and urine of patients with carcinoma of the bladder.
Iles RK; Lee CL; Oliver RT; Chard T
Clin Endocrinol (Oxf); 1990 Sep; 33(3):355-64. PubMed ID: 1701369
[TBL] [Abstract][Full Text] [Related]
13. [Qualitative analysis of the immunoreactive hCG beta-like substance produced by transitional cell carcinoma of the bladder].
Yamanaka N; Nishimura R
Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1150-6. PubMed ID: 1716709
[TBL] [Abstract][Full Text] [Related]
14. Primary choriocarcinoma of the urinary bladder.
Masui T; Asamoto M; Imaida K; Fukushima S; Okamura T; Ohtaguro K
Jpn J Clin Oncol; 1988 Mar; 18(1):59-64. PubMed ID: 2451042
[TBL] [Abstract][Full Text] [Related]
15. Treatment of bladder carcinoma using a germ cell chemotherapy protocol.
Williams G; Colbeck RA; Crawford SM
Br J Urol; 1990 May; 65(5):473-7. PubMed ID: 1693865
[TBL] [Abstract][Full Text] [Related]
16. Relation between basement membrane degradation and serum levels of laminin P1 in patients with transitional cell carcinoma of the bladder.
Abou Farha KM; Menheere PP; Nieman FH; Janknegt RA; Arends JW
Urol Int; 1993; 50(1):13-6. PubMed ID: 8434420
[TBL] [Abstract][Full Text] [Related]
17. Ectopic production of human chorionic gonadotropin by poorly differentiated transitional cell tumors of the urinary tract.
Wurzel RS; Yamase HT; Nieh PT
J Urol; 1987 Mar; 137(3):502-4. PubMed ID: 3820387
[TBL] [Abstract][Full Text] [Related]
18. [Expression of A,B and H blood group antigens in urothelial carcinoma of the urinary bladder].
Tichý M; Tichá V; Jansa P; Student V; Vanák J
Cesk Patol; 1991 Mar; 27(1-2):13-9. PubMed ID: 1893425
[TBL] [Abstract][Full Text] [Related]
19. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
[TBL] [Abstract][Full Text] [Related]
20. Serum and urine ferritin in patients with transitional cell carcinoma of the bladder.
Migliari R; Mela Q; Ruggiero V; Scarpa RM; Migliari M; Pitzus F; Usai E
Arch Ital Urol Nefrol Androl; 1991 Mar; 63(1):141-5. PubMed ID: 1830406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
